we performed a randomized , double-blind , placebo-controlled trial to assess the tolerance and efficacy of recombinant human interferon alpha 2a ( roferon a ) in patients with acquired immunodeficiency syndrome ( aids ) without kaposi 's sarcoma .
C0021734
recombinant
C0001175
acquired immunodeficiency syndrome